|
|
||||||||
Departments of Obstetrics and Gynecology and Biochemistry, University of Miami School of Medicine, Miami, Florida.
An improved sensitive assay for collagenase, which uses [3Hltelopeptide-free collagen as a substrate, was used to measure changes in serum collagenase levels in 96 women and ten men (18–35 years old). Both latent and active forms of collagenase were detected in serum by molecular sieve chromatography; these forms had a relative molecular weight (Mr of 65,000 and 45,000, respectively. Only latent collagenase was detected in crude serum after destroying inhibitors by treatment with 3 M potassium thiocyanate. Collagenase levels in males were lower than in nongravid females (34 ± 5 versus 53 ± 5 U/dL; mean ± SEM; 1 unit = 1 pg collagen digested per minute at 30C). During pregnancy there was no significant change in serum collagenase levels until the onset of spontaneous labor in full-term pregnancies (37–42 weeks), at which point there was a 66% increase over the nongravid level to a value of 88 ± 5 U/dL. There was a further rise at one day postpartum, and high levels continued for at least four days. Women in premature labor (24–36 weeks) exhibited an eightfold increase in the level of serum collagenase to 405 ± 110 U/dL; 16 of 17 patients in this group had collagenase levels above the 95th percentile for women at 16–40 weeks but not in labor. This evaluation of serum collagenase may provide a key for detecting premature labor. It is suggested that the increase in serum collagenase arises from the lower uterine segment and cervix. (Obstet Gynecol69:179, 1987)
This article has been cited by other articles:
![]() |
W. J. Inder, T. C. R. Prickett, M. J. Ellis, L. Hull, R. Reid, P. S. Benny, J. H. Livesey, and R. A. Donald The Utility of Plasma CRH as a Predictor of Preterm Delivery J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5706 - 5710. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vause and T. Johnston Management of preterm labour Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2000; 83(2): 79F - 85. [Full Text] |
||||
![]() |
E. R. Norwitz, J. N. Robinson, and J. R.G. Challis The Control of Labor N. Engl. J. Med., August 26, 1999; 341(9): 660 - 666. [Full Text] [PDF] |
||||
![]() |
H.-M. Tsai, I. I. Sussman, D. Ginsburg, H. Lankhof, J. J. Sixma, and R. L. Nagel Proteolytic Cleavage of Recombinant Type 2A von Willebrand Factor Mutants R834W and R834Q: Inhibition by Doxycycline and by Monoclonal Antibody VP-1 Blood, March 15, 1997; 89(6): 1954 - 1962. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Borczuk, K. H. van Hoeven, and S. M. Factor Review and hypothesis: the eosinophil and peripartum heart disease (myocarditis and coronary artery dissection)--coincidence or pathogenetic significance? Cardiovasc Res, March 1, 1997; 33(3): 527 - 532. [Abstract] [PDF] |
||||
![]() |
T. Freestone, R. J. Turner, A. Coady, D. J. Higman, R. M. Greenhalgh, and J. T. Powell Inflammation and Matrix Metalloproteinases in the Enlarging Abdominal Aortic Aneurysm Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1145 - 1151. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |